Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Merck & Co., Inc. (MRK)GlobeNewsWire • 02/13/25
Rosen Law Firm Urges Merck & Co., Inc. (NYSE: MRK) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their RightsBusiness Wire • 02/13/25
MRK INVESTOR ALERT: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitPRNewsWire • 02/13/25
Shareholders that lost money on Merck & Co., Inc. (MRK) should contact Levi & Korsinsky about pending Class Action - MRKAccesswire • 02/12/25
MRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead the Merck Class Action LawsuitGlobeNewsWire • 02/12/25
Rosen Law Firm Encourages Merck & Co. Inc. Investors to Inquire About Securities Class Action Investigation – MRKBusiness Wire • 02/12/25
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Merck & Co., Inc. Securities and Sets a Lead Plaintiff Deadline of April 14, 2025GlobeNewsWire • 02/12/25
Merck Employees Federal Credit Union Partners with Carefull to Combat Rising Elder Fraud and Scam ThreatsBusiness Wire • 02/12/25
Levi & Korsinsky Reminds Shareholders of an Investigation into Merck & Co., Inc. (MRK) Regarding Potential Securities Fraud AllegationsAccesswire • 02/12/25
An Investigation Has Commenced on Behalf of Merck & Co., Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MRK Losses.Accesswire • 02/11/25
ATTENTION Merck & Co., Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your RightsAccesswire • 02/10/25
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What's Next?24/7 Wall Street • 02/07/25
Merck & Co., Inc. (MRK) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsAccesswire • 02/07/25
Investors who lost money on Merck & Co., Inc. should contact Levi & Korsinsky about an ongoing investigation - MRKAccesswire • 02/06/25
Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell LymphomaBusiness Wire • 02/06/25